There isn’t specific public information showing when Zenegra 100 mg was “integrated with other languages” (as in translated labeling or documentation) because this isn’t usually documented in a centralized way for generic medicines. What is available relates to its market presence and distribution over time:

Zenegra 100 mg, like other generic Sildenafil products, has been exported to multiple countries since at least 2016, indicating wide international distribution which typically involves localized packaging and language adaptations depending on the destination market. Export records show shipments to countries including Singapore, Lesotho, and others starting in early 2016.

Generic sildenafil itself (the active ingredient in Zenegra 100 has a long history of global use since the original compound was approved in 1998 for erectile dysfunction, and over time many generics have been translated into local languages for markets around the world.

In practice, “integration with other languages” for a pharmaceutical product typically happens during regulatory approval and marketing in specific countries. When a company like Alkem Laboratories registers Zenegra in a new country or region, the labeling, package inserts, and patient information leaflets are translated into that country’s official languages as part of the regulatory process before approval.

Unfortunately, there is no single published date or event stating exactly when Zenegra 100 mg labels or documentation were first translated into particular languages. Because this is determined by regulatory approvals in different regions, the timing varies by country and is usually recorded in each country’s drug regulatory database rather than in global summaries.

If you need information about specific language approvals (e.g., when Zenegra 100 mg materials became available in French, Spanish, etc.) for a specific country, I can help look up country‑specific regulatory data.